Collegium Pharmaceutical Statistics
Total Valuation
COLL has a market cap or net worth of $1.14 billion. The enterprise value is $1.87 billion.
| Market Cap | 1.14B |
| Enterprise Value | 1.87B |
Important Dates
The next confirmed earnings date is Thursday, November 6, 2025, before market open.
| Earnings Date | Nov 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
COLL has 31.50 million shares outstanding. The number of shares has decreased by -11.15% in one year.
| Current Share Class | 31.50M |
| Shares Outstanding | 31.50M |
| Shares Change (YoY) | -11.15% |
| Shares Change (QoQ) | +18.99% |
| Owned by Insiders (%) | 0.83% |
| Owned by Institutions (%) | 103.72% |
| Float | 28.10M |
Valuation Ratios
The trailing PE ratio is 34.09 and the forward PE ratio is 4.99.
| PE Ratio | 34.09 |
| Forward PE | 4.99 |
| PS Ratio | 1.63 |
| Forward PS | 1.46 |
| PB Ratio | 4.90 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 5.64 |
| P/OCF Ratio | 5.59 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.97, with an EV/FCF ratio of 9.25.
| EV / Earnings | 51.47 |
| EV / Sales | 2.64 |
| EV / EBITDA | 4.97 |
| EV / EBIT | 11.36 |
| EV / FCF | 9.25 |
Financial Position
The company has a current ratio of 1.18, with a Debt / Equity ratio of 4.10.
| Current Ratio | 1.18 |
| Quick Ratio | 0.94 |
| Debt / Equity | 4.10 |
| Debt / EBITDA | 2.51 |
| Debt / FCF | 4.72 |
| Interest Coverage | 2.00 |
Financial Efficiency
Return on equity (ROE) is 16.16% and return on invested capital (ROIC) is 10.48%.
| Return on Equity (ROE) | 16.16% |
| Return on Assets (ROA) | 7.76% |
| Return on Invested Capital (ROIC) | 10.48% |
| Return on Capital Employed (ROCE) | 14.57% |
| Revenue Per Employee | $1.98M |
| Profits Per Employee | $101,599 |
| Employee Count | 357 |
| Asset Turnover | 0.53 |
| Inventory Turnover | 2.68 |
Taxes
In the past 12 months, COLL has paid $16.73 million in taxes.
| Income Tax | 16.73M |
| Effective Tax Rate | 31.56% |
Stock Price Statistics
The stock price has increased by +7.89% in the last 52 weeks. The beta is 0.65, so COLL's price volatility has been lower than the market average.
| Beta (5Y) | 0.65 |
| 52-Week Price Change | +7.89% |
| 50-Day Moving Average | 35.70 |
| 200-Day Moving Average | 31.67 |
| Relative Strength Index (RSI) | 59.36 |
| Average Volume (20 Days) | 327,075 |
Short Selling Information
The latest short interest is 5.23 million, so 16.61% of the outstanding shares have been sold short.
| Short Interest | 5.23M |
| Short Previous Month | 5.19M |
| Short % of Shares Out | 16.61% |
| Short % of Float | 18.62% |
| Short Ratio (days to cover) | 14.17 |
Income Statement
In the last 12 months, COLL had revenue of $707.01 million and earned $36.27 million in profits. Earnings per share was $1.06.
| Revenue | 707.01M |
| Gross Profit | 618.71M |
| Operating Income | 164.33M |
| Pretax Income | 53.00M |
| Net Income | 36.27M |
| EBITDA | 375.77M |
| EBIT | 164.33M |
| Earnings Per Share (EPS) | $1.06 |
Balance Sheet
The company has $222.15 million in cash and $951.74 million in debt, giving a net cash position of -$729.58 million or -$23.16 per share.
| Cash & Cash Equivalents | 222.15M |
| Total Debt | 951.74M |
| Net Cash | -729.58M |
| Net Cash Per Share | -$23.16 |
| Equity (Book Value) | 232.21M |
| Book Value Per Share | 7.36 |
| Working Capital | 84.60M |
Cash Flow
In the last 12 months, operating cash flow was $203.48 million and capital expenditures -$1.68 million, giving a free cash flow of $201.81 million.
| Operating Cash Flow | 203.48M |
| Capital Expenditures | -1.68M |
| Free Cash Flow | 201.81M |
| FCF Per Share | $6.41 |
Margins
Gross margin is 87.51%, with operating and profit margins of 23.24% and 5.13%.
| Gross Margin | 87.51% |
| Operating Margin | 23.24% |
| Pretax Margin | 7.50% |
| Profit Margin | 5.13% |
| EBITDA Margin | 53.15% |
| EBIT Margin | 23.24% |
| FCF Margin | 28.54% |
Dividends & Yields
COLL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 11.15% |
| Shareholder Yield | 11.15% |
| Earnings Yield | 3.19% |
| FCF Yield | 17.75% |
Analyst Forecast
The average price target for COLL is $44.25, which is 22.58% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $44.25 |
| Price Target Difference | 22.58% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 3.51% |
| EPS Growth Forecast (5Y) | 33.95% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
COLL has an Altman Z-Score of 1.17 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.17 |
| Piotroski F-Score | 7 |